Clinical Trials in Philadelphia

Showing 5641-5660 of 20,904 trials

An Open-Label Multiple Dose Study of RZ358 in Patients With Congenital Hyperinsulinism

NCT04538989

The objective of this trial is to evaluate the safety, tolerability and glucose-raising effects of RZ358 in patients with Congenital Hyperinsulinism (HI).

Congenital Hyperinsulinism

Rezolute23 participantsStarted Feb 2020

Philadelphia, Pennsylvania, United States • Fort Worth, Texas, United States • Sofia, Bulgaria +14 more locations

COMPLETEDNA< 1 mile

Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the BWI IRE Ablation System

NCT05293639

To demonstrate the safety and 12-month effectiveness of the VARIPULSE™ Catheter when used in conjunction with the TRUPULSE™ Generator for pulmonary vein isolation (PVI) in the treatment of subjects with symptomatic paroxysmal atrial fibrillation.

Atrial Fibrillation

Biosense Webster, Inc.362 participantsStarted Apr 2022

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Jonesboro, Arkansas, United States +27 more locations

An Open-Label Multiple Dose Study of RZ358 in Patients With Congenital Hyperinsulinism

Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the BWI IRE Ablation System

Find Trials by Condition in Philadelphia

A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Safety, Tolerability and Immunogenicity Study of Different Vaccine Regimens of Trivalent Ad26.Mos.HIV or Tetravalent Ad26.Mos4.HIV Along With Clade C Glycoprotein (gp)140 in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Adults

Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Hybrid Coronary Revascularization Trial

Phase1 First in Human Ascending Dose Study to Evaluate the Safety and Tolerability of FC-12738 in Health Adults

Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease

A Study of Ad26.COV2.S and Influenza Vaccines in Healthy Adults

Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 2)

Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer

A Study of PCI-32765 (Ibrutinib) in Combination With Either Bendamustine and Rituximab or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Participants With Previously Treated Indolent Non-Hodgkin Lymphoma

A Clinical Study on Implants With TiUltra Technology and Associated Prosthetic Components

Validation of CardioMEMS HF System Cardiac Output Algorithm IDE

A Study of the Efficacy and Safety of Frespaciguat (MK-5475) in Participants With Pulmonary Arterial Hypertension (INSIGNIA-PAH: Phase 2/3 Study of an Inhaled sGC Stimulator in PAH) (MK-5475-007)

Conduction System Pacing With INGEVITY+

Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine

HbA1c Variation Study

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Participants

A Study of Ad26.COV2.S in Healthy Pregnant Participants (COVID-19)